In that sense, several reviews have reported an association between the impairment of the gut barrier function parameters and several diseases, among which are inflammatory bowel disease (IBD) through pro-inflammatory cytokine-mediated responses [2], obesity and/or type 2 diabetes through innate chemokine signaling, eosinophils, immunoglobulin A (IgA), T helper (Th) 17 cells and their cytokines [3], food allergy diseases [4], and even skin diseases [5]. Here, CD79A is linked to inflammatory bowel disease.